Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker SOPH
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | Kathy L. Hibbs Director | SOPH SOPHiA GENETICS SA | Sale | 6,250 | $7.76 | $48.5K Sale | Form 4 ↗ |
| Nov 10, 2026 | Jurgi Camblong Executive Chairman, Director | SOPH SOPHiA GENETICS SA | Sale | 8,500 | $7.76 | $65.9K Sale | Form 4 ↗ |
| Nov 9, 2026 | Daan Van Well Chief Legal Officer | SOPH SOPHiA GENETICS SA | Sale | 1,411 | $7.44 | $10.5K Sale | Form 4 ↗ |
| Nov 6, 2026 | George Cardoza Chief Financial Officer | SOPH SOPHiA GENETICS SA | Buy | 20,000 | $7.06 | $141.2K Buy | Form 4 ↗ |
| Nov 6, 2026 | Ross Muken Chief Executive Officer, Director | SOPH SOPHiA GENETICS SA | Buy | 20,000 | $6.86 | $137.2K Buy | Form 4 ↗ |
| Sep 21, 2026 | George Cardoza Chief Financial Officer | SOPH SOPHiA GENETICS SA | Sale | 774 | $8.33 | $6,447 Sale | Form 4 ↗ |
| Sep 21, 2026 | Ross Muken Chief Executive Officer, Director | SOPH SOPHiA GENETICS SA | Sale | 422 | $8.33 | $3,515 Sale | Form 4 ↗ |
| Sep 14, 2026 | Philippe Menu Chief Medical Officer | SOPH SOPHiA GENETICS SA | Sale | 5,000 | $7.88 | $39.4K Sale | Form 4 ↗ |
| Sep 14, 2026 | Zhenyu Xu Chief Scientific Officer | SOPH SOPHiA GENETICS SA | Sale | 4,000 | $7.88 | $31.5K Sale | Form 4 ↗ |
| Sep 11, 2026 | Daan Van Well Chief Legal Officer | SOPH SOPHiA GENETICS SA | Sale | 6,168 | $7.63 | $47.1K Sale | Form 4 ↗ |
| Sep 10, 2026 | Jurgi Camblong Executive Chairman, Director | SOPH SOPHiA GENETICS SA | Sale | 8,500 | $7.66 | $65.1K Sale | Form 4 ↗ |
| Sep 8, 2026 | Kathy L. Hibbs Director | SOPH SOPHiA GENETICS SA | Sale | 6,250 | $8.13 | $50.8K Sale | Form 4 ↗ |
| Aug 27, 2026 | Zhenyu Xu Chief Scientific Officer | SOPH SOPHiA GENETICS SA | Sale | 10,000 | $8.91 | $89.1K Sale | Form 4 ↗ |
| Aug 25, 2026 | Philippe Menu Chief Medical Officer | SOPH SOPHiA GENETICS SA | Sale | 5,000 | $8.68 | $43.4K Sale | Form 4 ↗ |
| Aug 25, 2026 | Kathy L. Hibbs Director | SOPH SOPHiA GENETICS SA | Sale | 6,250 | $8.68 | $54.3K Sale | Form 4 ↗ |
| Aug 24, 2026 | Abhimanyu Verma Chief Technology Officer | SOPH SOPHiA GENETICS SA | Sale | 5,000 | $8.80 | $44.0K Sale | Form 4 ↗ |
| Aug 21, 2026 | Zhenyu Xu Chief Scientific Officer | SOPH SOPHiA GENETICS SA | Sale | 5,408 | $8.40 | $45.4K Sale | Form 4 ↗ |
| Aug 20, 2026 | Zhenyu Xu Chief Scientific Officer | SOPH SOPHiA GENETICS SA | Sale | 4,592 | $8.41 | $38.6K Sale | Form 4 ↗ |
| Aug 19, 2026 | Abhimanyu Verma Chief Technology Officer | SOPH SOPHiA GENETICS SA | Sale | 5,000 | $8.20 | $41.0K Sale | Form 4 ↗ |
| Aug 19, 2026 | Manuela Valente Chief People Officer | SOPH SOPHiA GENETICS SA | Sale | 10,000 | $7.94 | $79.4K Sale | Form 4 ↗ |
| Aug 19, 2026 | Zhenyu Xu Chief Scientific Officer | SOPH SOPHiA GENETICS SA | Sale | 10,000 | $7.94 | $79.4K Sale | Form 4 ↗ |
| Aug 13, 2026 | Zhenyu Xu Chief Scientific Officer | SOPH SOPHiA GENETICS SA | Sale | 4,000 | $7.52 | $30.1K Sale | Form 4 ↗ |
| Aug 12, 2026 | Philippe Menu Chief Medical Officer | SOPH SOPHiA GENETICS SA | Sale | 5,000 | $7.52 | $37.6K Sale | Form 4 ↗ |
| Aug 10, 2026 | Jurgi Camblong Executive Chairman, Director | SOPH SOPHiA GENETICS SA | Sale | 8,500 | $7.61 | $64.7K Sale | Form 4 ↗ |
| Aug 7, 2026 | Abhimanyu Verma Chief Technology Officer | SOPH SOPHiA GENETICS SA | Sale | 5,000 | $7.60 | $38.0K Sale | Form 4 ↗ |
| Aug 7, 2026 | Jurgi Camblong Executive Chairman, Director | SOPH SOPHiA GENETICS SA | Sale | 20,000 | $7.23 | $144.6K Sale | Form 4 ↗ |
| Aug 7, 2026 | Zhenyu Xu Chief Scientific Officer | SOPH SOPHiA GENETICS SA | Sale | 10,000 | $7.48 | $74.8K Sale | Form 4 ↗ |
| Aug 7, 2026 | Zhenyu Xu Chief Scientific Officer | SOPH SOPHiA GENETICS SA | Sale | 7,000 | $7.02 | $49.1K Sale | Form 4 ↗ |
| Aug 5, 2026 | Zhenyu Xu Chief Scientific Officer | SOPH SOPHiA GENETICS SA | Sale | 3,000 | $7.00 | $21.0K Sale | Form 4 ↗ |
| Aug 4, 2026 | Abhimanyu Verma Chief Technology Officer | SOPH SOPHiA GENETICS SA | Sale | 5,000 | $6.95 | $34.8K Sale | Form 4 ↗ |
| Aug 4, 2026 | Jurgi Camblong Executive Chairman, Director | SOPH SOPHiA GENETICS SA | Sale | 20,000 | $6.92 | $138.4K Sale | Form 4 ↗ |
| Aug 4, 2026 | Zhenyu Xu Chief Scientific Officer | SOPH SOPHiA GENETICS SA | Sale | 10,000 | $6.92 | $69.2K Sale | Form 4 ↗ |
| Jul 27, 2026 | Philippe Menu Chief Medical Officer | SOPH SOPHiA GENETICS SA | Sale | 5,000 | $5.66 | $28.3K Sale | Form 4 ↗ |
| Jul 21, 2026 | Jurgi Camblong Executive Chairman, Director | SOPH SOPHiA GENETICS SA | Sale | 20,000 | $6.63 | $132.6K Sale | Form 4 ↗ |
| Jul 20, 2026 | Jurgi Camblong Executive Chairman, Director | SOPH SOPHiA GENETICS SA | Sale | 4,581 | $6.17 | $28.3K Sale | Form 4 ↗ |
| Jul 20, 2026 | Jurgi Camblong Executive Chairman, Director | SOPH SOPHiA GENETICS SA | Sale | 19,800 | $6.32 | $125.1K Sale | Form 4 ↗ |
| Jul 13, 2026 | Philippe Menu Chief Medical Officer | SOPH SOPHiA GENETICS SA | Sale | 5,000 | $5.70 | $28.5K Sale | Form 4 ↗ |
| Jul 13, 2026 | Zhenyu Xu Chief Scientific Officer | SOPH SOPHiA GENETICS SA | Sale | 4,000 | $5.70 | $22.8K Sale | Form 4 ↗ |
| Jul 10, 2026 | Jurgi Camblong Executive Chairman, Director | SOPH SOPHiA GENETICS SA | Sale | 8,500 | $5.62 | $47.8K Sale | Form 4 ↗ |
| Jul 7, 2026 | Jurgi Camblong Executive Chairman, Director | SOPH SOPHiA GENETICS SA | Sale | 17,685 | $5.28 | $93.4K Sale | Form 4 ↗ |
| Jul 6, 2026 | George Cardoza Chief Financial Officer | SOPH SOPHiA GENETICS SA | Sale | 1,592 | $5.29 | $8,422 Sale | Form 4 ↗ |
| Jul 6, 2026 | Manuela Valente Chief People Officer | SOPH SOPHiA GENETICS SA | Sale | 4,241 | $5.05 | $21.4K Sale | Form 4 ↗ |
| Jul 6, 2026 | Abhimanyu Verma Chief Technology Officer | SOPH SOPHiA GENETICS SA | Sale | 5,285 | $5.10 | $27.0K Sale | Form 4 ↗ |
| Jul 6, 2026 | Zhenyu Xu Chief Scientific Officer | SOPH SOPHiA GENETICS SA | Sale | 7,393 | $5.17 | $38.2K Sale | Form 4 ↗ |
| Jul 6, 2026 | Ross Muken Chief Executive Officer, Director | SOPH SOPHiA GENETICS SA | Sale | 9,838 | $5.22 | $51.4K Sale | Form 4 ↗ |
| Jul 6, 2026 | Kevin Puylaert Chief Sales Officer | SOPH SOPHiA GENETICS SA | Sale | 31 | $5.09 | $158 Sale | Form 4 ↗ |
| Jul 6, 2026 | Kevin Puylaert Chief Sales Officer | SOPH SOPHiA GENETICS SA | Sale | 47 | $5.03 | $236 Sale | Form 4 ↗ |
| Jul 6, 2026 | Kevin Puylaert Chief Sales Officer | SOPH SOPHiA GENETICS SA | Sale | 138 | $5.03 | $694 Sale | Form 4 ↗ |
| Jul 6, 2026 | Philippe Menu Chief Medical Officer | SOPH SOPHiA GENETICS SA | Sale | 7,393 | $5.16 | $38.1K Sale | Form 4 ↗ |
| Jul 6, 2026 | Jurgi Camblong Executive Chairman, Director | SOPH SOPHiA GENETICS SA | Sale | 22,486 | $5.26 | $118.3K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:15 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances